Enrollment is now complete in the CORAL clinical trial of nalbuphine ER, to be marketed as Haduvio, for IPF patients with ...

First columnist Sam Kirton's truck malfunctioned. Then he received some unfortunate medical news. It was just one of those days.

CS014 has shown the ability to reverse scarring and ease blood vessel remodeling in a preclinical model of pulmonary arterial ...

Joining the IPF community may not be voluntary, columnist Sam Kirton says, but he's grateful for the fraternity he's found along the way.

Visit the Pulmonary Fibrosis News forums to connect with others in the PF community.

Nerandomilast, an oral treatment being developed by Boehringer Ingelheim, bested a placebo at preserving lung function in adults with progressive pulmonary fibrosis in a Phase 3 study, according to ...

Living with a rare lung disease such as pulmonary fibrosis (PF) is a daily battle that requires strength and perseverance. Many individuals, me included, face this journey with courage, often in the ...

A protein called Runx2 contributes to the abnormal activity of lung cells that drive pulmonary fibrosis, a new study shows, suggesting that inhibiting this protein may be an effective strategy for ...